-
BOP Reagent for Peptide and Prodrug Design
2026-09-08
BOP reagent is a solid peptide coupling reagent for carboxyl group activation and amide bond formation. The supplier reports 98% purity, organic-solvent solubility, and desiccated storage at −20 °C, while current OSCC evidence supports a separate carrier-free triterpene prodrug platform rather than direct evidence for BOP use.
-
Triterpene Prodrug for Targeted OSCC Therapy
2026-09-08
This study develops a carrier-free, self-assembled prodrug from glycyrrhetinic acid and ginsenoside Rh2 for targeted oral squamous cell carcinoma chemotherapy. Its central innovation is a thioketal-linked glycyrrhetinic acid dimer that uses tumor-associated reactive oxygen species to trigger drug release while glycyrrhetinic acid amplifies oxidative stress.
-
G-15: G Protein-Coupled Estrogen Receptor Antagonist
2026-09-07
G-15 is a selective G protein-coupled estrogen receptor antagonist for separating GPR30/GPER signaling from classical estrogen receptor activity. This guide translates its reported calcium, PI3K/Akt, proliferation, and in vivo effects into practical assay workflows, controls, and troubleshooting strategies.
-
Cefodizime Workflows for Resistance Research
2026-09-07
Build susceptibility, resistance-surveillance, and immune-interaction assays around Cefodizime, a third-generation cephalosporin antibiotic with defined Gram-positive and Gram-negative activity. This workflow translates hospital utilization data into practical experimental controls while highlighting target-organism limitations and reproducibility safeguards.
-
Proteinase K for DNA Prep and Protease Assays
2026-09-05
Proteinase K combines broad protein hydrolysis with compatibility across buffers, detergents, EDTA, and moderate heating, making it useful for high-integrity DNA preparation and enzyme-contaminant removal. Its contrasting behavior in a SARS-CoV-2 protease screen also makes it a practical counter-screen for separating selective inhibitor activity from nonspecific protease inhibition.
-
3X FLAG Peptide: From Tag to Translation
2026-09-04
A mechanistic and strategic guide to using the 3X (DYKDDDDK) Peptide in interactome analysis, FLAG fusion-protein workflows, structural biology, and translational research. The article connects the CUL3-KEAP1–PHD2 study to practical decisions around affinity capture, immunodetection, metal control, and evidence quality.
-
Chenodeoxycholic Acid: FXR Research Workflows
2026-09-04
Chenodeoxycholic Acid provides a practical chemical entry point for activating FXR in cholesterol metabolism research, liver function studies, and renal injury models. This workflow translates the reported FXR–KLF11 mechanism into formulation, cell-based, transcriptional, and troubleshooting strategies while separating established findings from optimization starting points.
-
HATU for Precise Peptide Coupling Workflows
2026-09-03
HATU streamlines carboxylic acid activation for challenging amide and ester formation, from peptide synthesis chemistry to medicinal chemistry libraries. This guide connects practical coupling conditions with the stereochemically defined inhibitor design reported for IRAP and related aminopeptidases.
-
Pertussis Toxin as a Causal Signaling Probe
2026-09-03
Pertussis toxin is more than an immune-modulating reagent: it is a causal probe for Gi/o-linked cAMP signaling. This article connects dendritic-cell assays with a 2024 mouse pharmacology study to show how pathway perturbation, receptor selectivity, and experimental controls should guide interpretation.
-
Cyclo (-RGDfC) for Integrin Targeting Workflows
2026-09-02
Cyclo (-RGDfC) converts αvβ3 integrin biology into practical adhesion, migration, angiogenesis, and targeted-delivery assays. Its cyclic c(RGDfC) scaffold supports receptor-focused experiments while the canine osteosarcoma reference study provides a useful framework for separating viability effects from mechanism-specific readouts.
-
CD38 CAR Binders: Structure-Guided Affinity Tuning
2026-09-02
This iScience study combines crystal structures, residue-level mutagenesis, enzymatic assays, and CAR-T functional testing to explain how RP02 and 028 engage CD38 differently. Its key contribution is a structure-guided affinity-tuning strategy in which an attenuated 028 variant reduced fratricide while preserving cytotoxicity against CD38-positive tumor cells.
-
HyperScribe T7 High Yield RNA Synthesis Kit Plus: Workflow
2026-09-01
The HyperScribe T7 High Yield RNA Synthesis Kit Plus combines high-yield T7 transcription with support for capped, dye-labeled, and biotinylated RNA formats. This workflow explains how to turn a linearized DNA template into research-grade RNA for mRNA rescue studies, RNA interference experiments, probe assays, and other demanding applications.
-
Nullscript: Histone Deacetylase Inhibitor Workflow
2026-09-01
Nullscript is a histone deacetylase inhibitor for separating HDAC blockade from transcriptional facilitation in cardiac, metabolic, and cell-based studies. Its scriptaid-like structure, inactive p6SBE-luc profile, and reported cardiac ischemia/reperfusion benefit make it especially useful for assay-first mechanism testing.
-
3X (DYKDDDDK) Peptide: FLAG Workflow Guide
2026-08-31
The 3X (DYKDDDDK) Peptide supports sensitive FLAG-tag capture, competitive elution, and orthogonal immunodetection in recombinant-protein workflows. This guide translates the MAZ–BCKDK–G6PD findings in triple-negative breast cancer into practical assay designs while addressing metal sensitivity, tag accessibility, and crystallization readiness.
-
Engineering a Simpler Bitespiramycin Producer
2026-08-31
The reference study used an in-frame partial deletion of sspA, encoding a 3-O-acyltransferase, to simplify the product profile of a recombinant bitespiramycin-producing Streptomyces strain. The resulting WSJ-2 strain was reported to produce predominantly 4″-isovalerylspiramycin I, illustrating how targeted pathway engineering can improve compositional control without redesigning the entire biosynthetic system.